|
Index of reports
> Cases with Pyrexia (278)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cyclophosphamide where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 278 Next >>
Possible Cyclophosphamide side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Cyclophosphamide side effects in 52 year old female
Reported by a physician from United Kingdom on 2012-08-24
Patient: 52 year old female, weighing 83.3 kg (183.3 pounds)
Reactions: Neutropenic Sepsis, Pyrexia, Diarrhoea Infectious
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 mg/m2, every 3 weeks
Indication: Breast Cancer
Start date: 2012-07-02
Cyclophosphamide
Dosage: 1000 mg/m2, every 3 weeks
Epirubicin Hydrochloride
Dosage: 100 mg/m2, every 3 weeks
Indication: Breast Cancer
Start date: 2012-07-02
Epirubicin Hydrochloride
Dosage: 200 mg/m2, every 3 weeks
Fluorouracil
Dosage: 500 mg, every 3 weeks
Indication: Breast Cancer
Start date: 2012-07-02
Fluorouracil
Dosage: 1000 mg/m2, every 3 weeks
Pertuzumab
Indication: Breast Cancer
Trastuzumab
Indication: Breast Cancer
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 121.9 kg (268.2 pounds)
Reactions: Pruritus, Unresponsive To Stimuli, Device Related Infection, Pyrexia, Candidiasis, Abscess Limb, Ventricular Extrasystoles, Metabolic Acidosis, Dyspnoea, Hypotension, Pancytopenia, Tremor, Convulsion, Respiratory Failure, Fungal Infection, Ventricular Tachycardia, Sepsis, Respiratory Arrest, Pulse Absent, Sinus Tachycardia, Hypertension, Feeling Abnormal, Cardiac Arrest, Escherichia Infection, Infusion Related Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 74.4 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Cyclophosphamide
Dosage: daily for 5 days
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Epinephrine
Dosage: 4 df, unk
Indication: Cardiac Arrest
Start date: 2012-07-14
End date: 2012-07-14
Epinephrine
Dosage: unk
Start date: 2012-07-14
End date: 2012-07-14
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Oncaspar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-02
End date: 2012-07-02
Vincristine Sulfate
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-02
End date: 2012-07-02
Other drugs received by patient: Colace; Bactrim; Stomatitis Mouthwash; Prilosec; Lortab; Cymbalta; Ondansetron; Ambien
Possible Cyclophosphamide side effects in 65 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)
Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-03-16
Adriamycin PFS
Dosage: 40 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Carboplatin
Dosage: 250 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Cyclophosphamide
Dosage: 350 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Etoposide
Dosage: 100 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Prednisolone
Dosage: 1mg/kg x 1/2 week
Start date: 2011-12-13
End date: 2011-12-14
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Start date: 2011-03-16
Prednisolone
Dosage: 2 mg/m2, 1x/day
Administration route: Oral
Start date: 2011-03-24
Ranimustine
Dosage: 60 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-16
Vincristine Sulfate
Dosage: 1 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Vindesine Sulfate
Dosage: 2.4 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium
Possible Cyclophosphamide side effects in 49 year old male
Reported by a physician from Norway on 2012-08-24
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Cyclophosphamide side effects in female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-23
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Graft Versus Host Disease, Staphylococcal Infection, Chills, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 4380 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-11
Other drugs received by patient: Sulfamethoxazole Trimethoprim
Possible Cyclophosphamide side effects in male
Reported by a individual with unspecified qualification from United States on 2012-08-23
Patient: male, weighing 26.9 kg (59.2 pounds)
Reactions: Abdominal Pain, Dyspnoea, Dilatation Ventricular, Tachycardia, Fungal Sepsis, Status Epilepticus, Pyrexia, Hemiparesis, Breath Sounds Abnormal, Hypophagia, Hypomagnesaemia, Acute Respiratory Distress Syndrome, Shunt Malfunction, Neutropenia, Blood Pressure Decreased, Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 74 mg
Cyclophosphamide
Dosage: 1960 mg
G-CSF (Filgrastim, Amgen)
Dosage: 135 mg
Isotretinoin
Dosage: 80 mg
Vincristine Sulfate
Dosage: 2.8 mg
Possible Cyclophosphamide side effects in male
Reported by a consumer/non-health professional from France on 2012-08-23
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Abdominal Pain Lower, Bronchopulmonary Aspergillosis, Prostatitis, Cystitis Haemorrhagic, Human Polyomavirus Infection, Pyrexia, Dysuria, Adenovirus Infection, Pollakiuria
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, 3 times per 1 cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Valganciclovir; Bactrim; Folic Acid; Vfend
Possible Cyclophosphamide side effects in female
Reported by a individual with unspecified qualification from United States on 2012-08-23
Patient: female, weighing 81.8 kg (180.0 pounds)
Reactions: Dyspnoea, Chest Pain, Pancytopenia, Pyrexia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1400 mg
Doxorubicin Hydrochloride
Dosage: 94 mg
Prednisone
Dosage: 375 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 700 mg
Vincristine Sulfate
Dosage: 2 mg
Possible Cyclophosphamide side effects in 49 year old male
Reported by a physician from Norway on 2012-08-23
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Septic Shock, Lung Infiltration
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Baxter 15 000 IE Lyofilisat TIL Injeksjonsv?ske / Infusjonsv?s
Cyclophosphamide
Cyclophosphamide
Doxorubicin Hydrochloride
Doxorubicin Hydrochloride
Etoposide
Etoposide
Prednisolone
Administration route: Oral
Procarbazine Hydrochloride
Administration route: Oral
Vincristine
Possible Cyclophosphamide side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Tachycardia, Clostridium Difficile Colitis, Pancytopenia, Neutropenia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 2780 mg
Doxorubicin Hydrochloride
Dosage: 152 mg
Etoposide
Dosage: 720 mg
Fluorine-18 2-Fluorou-2 Deoxyry-D-Glucose (18f-Fdg)
Dosage: 12 mg
Prednisone
Dosage: 1300 mg
Rituximab
Dosage: 800 mg
Vincristine Sulfate
Dosage: 3.6 mg
Possible Cyclophosphamide side effects in male
Reported by a consumer/non-health professional from France on 2012-08-17
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Abdominal Pain Lower, Prostatitis, Adenovirus Infection, Dysuria, Cystitis Haemorrhagic, Pollakiuria, Human Polyomavirus Infection, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, 3 times per 1 cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Valganciclovir; Vfend; Folic Acid; Bactrim
Possible Cyclophosphamide side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: female, weighing 87.8 kg (193.2 pounds)
Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Pyrexia, Leukocytosis, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Cytarabine
Dosage: 1.87 g, cyclic
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, unk
Indication: Mantle Cell Lymphoma
Mesna
Dosage: 600 mg/m2, unk
Indication: Mantle Cell Lymphoma
Methotrexate
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: 1 mg/m2, cyclic
Indication: Mantle Cell Lymphoma
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-03-19
Velcade
Dosage: 2.77 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-12-31
Velcade
Dosage: 0.7 mg/m2, cyclic
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-02-26
Vincristine
Dosage: 2 mg, cyclic
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Sennosides A+B; Nystatin; Diphenhydramine Hydrochloride; Neupogen; Fluconazole; Zofran; Valtrex; Sodium Chloride; Meperidine HCL; Potassium Chloride; Leucovorin Calcium; Zofran; Sodium Chloride; Sodium Chloride; Sodium Chloride; Heparin; Leucovorin Calcium; Allopurinol; Lovenox; Morphine; Senokot; Cipro / 00042702 /; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Tramadol; Sodium Bicarbonate
Possible Cyclophosphamide side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient: 61 year old female
Reactions: Mucosal Inflammation, Nausea, Pyrexia, Diffuse Large B-Cell Lymphoma Recurrent, Oral Herpes
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Methotrexate
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Cyclophosphamide side effects in male
Reported by a physician from United States on 2012-08-13
Patient: male, weighing 129.0 kg (283.8 pounds)
Reactions: Lung Disorder, Dyspnoea, Chills, Rhinorrhoea, Pyrexia, Hyperuricaemia, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1970 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 990 mg
Vincristine Sulfate
Dosage: 2 mg
Other drugs received by patient: Doxorubicin Hydrochloride
Possible Cyclophosphamide side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-10
Patient: female
Reactions: Acute Pulmonary Oedema, Weight Increased, Hypersensitivity, Skin Toxicity, Chills, Rash Papular, Crepitations, Pyrexia, Aplasia, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 2800 mg, qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2010-10-10
End date: 2010-10-13
Cyclosporine
Dosage: 200 mg, bid
Administration route: Oral
Indication: Immunosuppressant Drug Therapy
Start date: 2010-08-11
Prednisone TAB
Dosage: 56 mg, unk
Indication: Immunosuppressant Drug Therapy
Start date: 2010-08-16
Solu-Medrol
Dosage: 11 mg, qd
Indication: Immunosuppressant Drug Therapy
Start date: 2010-08-11
End date: 2010-08-15
Solu-Medrol
Dosage: 100 mg, qid
Start date: 2010-10-11
End date: 2010-10-15
Thymoglobulin
Dosage: 196 mg, qd
Indication: Immunosuppression
Start date: 2010-08-11
End date: 2010-08-15
Thymoglobulin
Dosage: 112 mg, qd
Start date: 2010-10-11
End date: 2010-10-13
Other drugs received by patient: Zovirax; Tazobactam; Vancomycin; Tazobactam
Possible Cyclophosphamide side effects in 46 year old female
Reported by a individual with unspecified qualification from United States on 2012-08-08
Patient: 46 year old female
Reactions: Dyspnoea, Pain in Extremity, Myelodysplastic Syndrome, General Physical Health Deterioration, Pyrexia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Skin Discolouration, Central Nervous System Infection, Small Intestinal Haemorrhage, Cough
Adverse event resulted in: death
Drug(s) suspected as cause:
Carmustine
Indication: Diffuse Large B-Cell Lymphoma
Carmustine
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Dosage: 400 ug, intravenous, every two months
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Idarubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Melphalan (Melphalan) (Melphalen)
Indication: Diffuse Large B-Cell Lymphoma
Melphalan Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Rituximab (Rituximab) (Rituximab)
Indication: Diffuse Large B-Cell Lymphoma
Rituximab (Rituximab) (Rituximab)
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Cyclophosphamide side effects in 19 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient: 19 year old female
Reactions: Dyspnoea, Pancytopenia, Pyrexia, Chronic Myeloid Leukaemia, Multi-Organ Failure, Fatigue, Neoplasm Malignant, Sepsis, Chest Pain
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Dosage: 8 consolidation cycles
Indication: Medulloblastoma
Cyclophosphamide
Dosage: 8 consolidation cycles
Indication: Medulloblastoma
Vincristine Sulfate
Dosage: weekly, followed by 8 consolidation cycles
Indication: Medulloblastoma
Possible Cyclophosphamide side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-03
Patient: 60 year old female
Reactions: Vascular Occlusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-18
End date: 2012-05-25
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-18
End date: 2012-05-21
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-18
End date: 2012-05-26
Possible Cyclophosphamide side effects in male
Reported by a individual with unspecified qualification from United States on 2012-08-02
Patient: male, weighing 85.9 kg (189.0 pounds)
Reactions: Penile Pain, Pyrexia, Erythema
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1635 mg
Doxorubicin Hydrochloride
Dosage: 88 mg
Etoposide
Dosage: 436 mg
Prednisone TAB
Dosage: 650 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 818 mg
Vincristine Sulfate
Dosage: 3.48 mg
Possible Cyclophosphamide side effects in female
Reported by a physician from United States on 2012-07-31
Patient: female, weighing 50.3 kg (110.7 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Epstein-Barr Virus Test Positive, Pyrexia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1275 mg
End date: 2012-05-16
Fludarabine Phosphate
Dosage: 129 mg
End date: 2012-05-16
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 850 mg
End date: 2012-05-14
Possible Cyclophosphamide side effects in 82 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30
Patient: 82 year old female
Reactions: Confusional State, Pyrexia, Lymphoma
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Mabthera
Indication: B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Other drugs received by patient: Methotrexate
Possible Cyclophosphamide side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 46 year old female
Reactions: Pain in Extremity, Anaemia, Pyrexia, Pallor, Stem Cell Transplant, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Blood Culture Positive, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Asthenia, Hepatosplenomegaly, Candidiasis, Cough
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carmustine
Cyclophosphamide
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Cytarabine
Dosage: 1.5 g/d/m2 (1 cycle)
Doxorubicin Hydrochloride
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Idarubicin HCL
Dosage: 12 mg/d/m2 (1 cycle)
Melphalan Hydrochloride
Oncovin
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Vorinostat
Dosage: 1 cycle
Administration route: Oral
Possible Cyclophosphamide side effects in male
Reported by a physician from Poland on 2012-07-30
Patient: male, weighing 88.0 kg (193.6 pounds)
Reactions: Visual Impairment, Pyrexia, Lacrimation Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Other drugs received by patient: Zocor; Prednisone; Kalipoz; Furosemidum; Aspirin; Bisoprolol Fumarate; Nitrendypina; Ramipril; Anesteloc; Fragmin
Possible Cyclophosphamide side effects in
Reported by a physician from Netherlands on 2012-07-30
Patient:
Reactions: Diarrhoea, Pyrexia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-11
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-15
Velcade
Dosage: 2.6 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-14
Possible Cyclophosphamide side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient: 46 year old female
Reactions: Pancreatic Infarction, Unresponsive To Stimuli, Myelodysplastic Syndrome, Pyrexia, Pallor, Cerebral Haemorrhage, Skin Discolouration, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Apnoea, Thrombocytopenia, Cough, Candidiasis, Hepatosplenomegaly, Dyspnoea, Pain in Extremity, Anaemia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Hemisensory Neglect, Lung Infiltration, Asthenia, Hepatic Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Carmustine
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Idarubicin HCL
Dosage: 12 mg/m2, unk
Indication: Myelodysplastic Syndrome
Oncovin
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Suberoylanilide Hydroxamic Acid
Dosage: 500 mg, tid
Administration route: Oral
Indication: Myelodysplastic Syndrome
Other drugs received by patient: Radiotherapy
Possible Cyclophosphamide side effects in 33 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-25
Patient: 33 year old female
Reactions: Hyperbilirubinaemia, Enterococcal Infection, Pyrexia, Chorioretinitis, Large Intestinal Ulcer, Abdominal Distension, Microsporidia Infection, Hydrocephalus, Meningitis, Papule, Retinal Haemorrhage, Pulmonary Alveolar Haemorrhage, Hepatic Enzyme Increased, Respiratory Failure, Diarrhoea, Fungal Infection, Aspartate Aminotransferase Increased, Dermal Cyst, Lung Infiltration, Macule, Inflammation
Adverse event resulted in: death
Drug(s) suspected as cause:
Alemtuzumab
Indication: Multiple Myeloma
Alemtuzumab
Indication: Prophylaxis
Cyclophosphamide
Indication: Multiple Myeloma
Cyclosporine
Indication: Prophylaxis
Cyclosporine
Indication: Stem Cell Transplant
Cyclosporine
Dosage: unk
Indication: Multiple Myeloma
Fludarabine Phosphate
Dosage: unk
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in 57 year old male
Reported by a physician from France on 2012-07-23
Patient: 57 year old male
Reactions: Alanine Aminotransferase Increased, Hypercreatininaemia, Oedema Peripheral, Neutropenia, Pyrexia, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-06-02
End date: 2012-06-04
Cyclophosphamide
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-04-28
End date: 2012-04-30
Fludarabine Phosphate
Start date: 2012-06-02
End date: 2012-06-04
Fludarabine Phosphate
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-04-28
End date: 2012-04-30
Mabthera
Start date: 2012-06-01
End date: 2012-06-04
Mabthera
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-04-27
End date: 2012-04-30
Other drugs received by patient: MAG 2; Valacyclovir Hydrochloride; Phosphoneuros; Dedrogyl; Bactrim DS; Difrarel 100; Escitalopram
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20
Patient: male
Reactions: Alanine Aminotransferase Increased, Oedema Peripheral, Neutropenia, Pyrexia, Rash Maculo-Papular, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Administration route: Oral
Start date: 2012-06-02
End date: 2012-06-04
Cyclophosphamide
Administration route: Oral
Start date: 2012-04-28
End date: 2012-04-30
Fludara
Administration route: Oral
Start date: 2012-04-28
End date: 2012-04-30
Fludara
Administration route: Oral
Start date: 2012-06-02
End date: 2012-06-04
Mabthera
Start date: 2012-06-01
End date: 2012-06-01
Mabthera
Start date: 2012-04-27
End date: 2012-04-27
Other drugs received by patient: Phosphoneuros; MAG 2; Dedrogyl; Valacyclovir Hydrochloride; Escitalopram; Bactrim; Difrarel
Possible Cyclophosphamide side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20
Patient: 44 year old female, weighing 55.5 kg (122.1 pounds)
Reactions: Abdominal Pain, Intestinal Ischaemia, Colitis Ischaemic, White Blood Cell Count Decreased, Vomiting, Blood Creatine Phosphokinase Increased, Gastrointestinal Necrosis, Pyrexia, Multi-Organ Failure, Diarrhoea, GAS Gangrene, Heart Rate Increased, Bone Marrow Failure, Neutropenia, Clostridial Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 7 cycles, total 4 courses
Indication: Breast Cancer
Start date: 2011-07-22
End date: 2011-09-22
Epirubicin
Dosage: 7 cycles, total 4 courses
Indication: Breast Cancer
Start date: 2011-07-22
End date: 2011-09-22
Taxotere
Dosage: 4 cycles, total 3 courses, dose taken once daily
Indication: Breast Cancer
Start date: 2011-10-14
End date: 2011-11-25
Other drugs received by patient: Leucon; Lorazepam; Decadron Phosphate; Lorazepam; Kytril; Prochlorperazine; Kytril; Cepharanthin; Decadron Phosphate; Marzulene S
Page 1 Next >>
|
